Trilogy Capital’s Vanguard Short-Term Inflation-Protected Securities Index Fund VTIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Buy
8,301
+119
+1% +$5.98K 0.02% 288
2026
Q1
$409K Sell
8,182
-69
-0.8% -$3.43K 0.02% 285
2025
Q4
$408K Sell
8,251
-255
-3% -$12.8K 0.02% 272
2025
Q3
$431K Sell
8,506
-284
-3% -$14.3K 0.02% 266
2025
Q2
$442K Sell
8,790
-120
-1% -$5.99K 0.02% 249
2025
Q1
$445K Buy
8,910
+2,403
+37% +$118K 0.02% 233
2024
Q4
$315K Sell
6,507
-888
-12% -$43.4K 0.02% 276
2024
Q3
$365K Buy
7,395
+3
+0% +$146 0.02% 261
2024
Q2
$359K Buy
+7,392
New +$355K 0.02% 251

Other funds holding VTIP

Trilogy Capital's VTIP Position: Q2 2026 in Review

Trilogy Capital increased its Vanguard Short-Term Inflation-Protected Securities Index Fund (VTIP) stake by 1.5% in Q2 2026, buying an estimated $5.98K and bringing the position to 8,301 shares worth $417K. The position accounts for 0.02% of the portfolio, ranked #288.

Trilogy Capital first reported a position in VTIP in Q2 2024 and has held it in 9 quarters since. The position peaked at $445K in Q1 2025. 172 funds tracked by Wall St. Rank hold VTIP as of Q2 2026.

  • Trilogy Capital held 8,301 shares of Vanguard Short-Term Inflation-Protected Securities Index Fund worth $417K as of Q2 2026.
  • Trilogy Capital bought 119 Vanguard Short-Term Inflation-Protected Securities Index Fund shares in Q2 2026, an estimated $5.98K.
  • Vanguard Short-Term Inflation-Protected Securities Index Fund made up 0.02% of Trilogy Capital's portfolio in Q2 2026, its #288 holding.
  • Trilogy Capital first reported a position in Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2024 and has held it in 9 quarters since.
  • Trilogy Capital's Vanguard Short-Term Inflation-Protected Securities Index Fund position peaked at $445K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Vanguard Short-Term Inflation-Protected Securities Index Fund as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.